No abstract available
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Carmustine / administration & dosage
-
Combined Modality Therapy
-
Cytarabine / administration & dosage
-
Female
-
Hematopoietic Stem Cell Transplantation* / adverse effects
-
Hematopoietic Stem Cell Transplantation* / mortality
-
Hodgkin Disease / drug therapy
-
Hodgkin Disease / mortality
-
Hodgkin Disease / therapy*
-
Humans
-
Lymphoma, Non-Hodgkin / drug therapy
-
Lymphoma, Non-Hodgkin / mortality
-
Lymphoma, Non-Hodgkin / therapy*
-
Male
-
Melphalan / administration & dosage
-
Middle Aged
-
Podophyllotoxin / administration & dosage
-
Prognosis
-
Remission Induction
-
Transplantation Conditioning / adverse effects
-
Transplantation, Autologous
Substances
-
Cytarabine
-
Podophyllotoxin
-
Melphalan
-
Carmustine